CN¥98.46
1.10%
Shanghai, Oct 09, 03:00 pm CST. Closed.
ISIN
CNE100003F01
Symbol
688185

Cansino Biologics Inc-h Target price 2026 - Analyst rating & recommendation

Cansino Biologics Inc-h Classifications & Recommendation

Buy
86%
Hold
14%

Cansino Biologics Inc-h Price Target

Target Price CN¥68.06
Price CN¥98.46
Deviation
Number of Estimates 3
3 Analysts have issued a price target Cansino Biologics Inc-h 2027 . The average Cansino Biologics Inc-h target price is CN¥68.06. This is lower than the current stock price. The highest price target is
CN¥70.07 28.84%
register free of charge
, the lowest is
CN¥67.40 31.55%
register free of charge
.
A rating was issued by 7 analysts: 6 Analysts recommend Cansino Biologics Inc-h to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cansino Biologics Inc-h stock has an average upside potential 2027 of . Most analysts recommend the Cansino Biologics Inc-h stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion CN¥ 1.07 1.46
26.18% 36.72%
EBITDA Margin 10.62% 22.85%
138.48% 115.14%
Net Margin 2.61% 9.08%
105.83% 247.92%

2 Analysts have issued a sales forecast Cansino Biologics Inc-h 2026 . The average Cansino Biologics Inc-h sales estimate is

CN¥1.5b
unlock
. This is
18.18% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CN¥1.5b 22.88%
unlock
, the lowest is
CN¥1.4b 14.70%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CN¥1.1b 26.18%
2026
CN¥1.5b 36.72%
unlock
2027
CN¥1.8b 20.41%
unlock
2028
CN¥2.6b 46.81%
unlock
2029
CN¥2.7b 6.24%
unlock

2 Cansino Biologics Inc-h Analysts have issued a net profit forecast 2026. The average Cansino Biologics Inc-h net profit estimate is

CN¥133m
unlock
. This is
226.28% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CN¥138m 239.20%
unlock
, the lowest is
CN¥129m 216.58%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CN¥27.9m 107.36%
2026
CN¥133m 375.78%
unlock
2027
CN¥198m 49.12%
unlock
2028
CN¥682m 244.88%
unlock
2029
CN¥829m 21.56%
unlock

Net Margin

2025 2.61% 105.83%
2026
9.08% 247.92%
unlock
2027
11.25% 23.90%
unlock
2028
26.42% 134.84%
unlock
2029
30.23% 14.42%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share CN¥ 0.11 0.58
107.19% 427.27%
P/E 171.03
EV/Sales 10.01

2 Analysts have issued a Cansino Biologics Inc-h forecast for earnings per share. The average Cansino Biologics Inc-h EPS is

CN¥0.58
unlock
. This is
262.50% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CN¥0.60 275.00%
unlock
, the lowest is
CN¥0.56 250.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CN¥0.11 107.19%
2026
CN¥0.58 427.27%
unlock
2027
CN¥0.86 48.28%
unlock
2028
CN¥2.96 244.19%
unlock
2029
CN¥3.60 21.62%
unlock

P/E ratio

Current 615.38 703.61%
2026
171.03 72.21%
unlock
2027
114.69 32.94%
unlock
2028
33.25 71.01%
unlock
2029
27.36 17.71%
unlock

Based on analysts' sales estimates for 2026, the Cansino Biologics Inc-h stock is valued at an EV/Sales of

10.01
unlock
and an P/S ratio of
10.60
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.83
2026
10.01 15.41%
unlock
2027
8.31 16.95%
unlock
2028
5.66 31.89%
unlock
2029
5.33 5.87%
unlock

P/S ratio

Current
2026
10.60 15.38%
unlock
2027
8.80 16.95%
unlock
2028
6.00 31.89%
unlock
2029
5.64 5.87%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today